NCT04537780View on ClinicalTrials.gov

Efficacy and Safety of Montelukast in Non Alcoholic Steatohepatitis (NASH)

PHASE4CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

August 20, 2019

Primary Completion Date

August 30, 2020

Study Completion Date

August 30, 2020

Conditions
Non Alcoholic Steatohepatitis
Interventions
OTHER

Placebo

Placebo tabled every day

DRUG

Montelukast

Montelukast 10 mg daily at bed time.

Trial Locations (1)

31527

Dr. Tarek Mohamed Mostafa, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT04537780 - Efficacy and Safety of Montelukast in Non Alcoholic Steatohepatitis (NASH) | Biotech Hunter | Biotech Hunter